Free Access
J Extra Corpor Technol
Volume 44, Number 1, March 2012
Page(s) 15 - 20
Published online 15 March 2012
  1. Anderson JA, Saenko EL. Heparin resistance. Br J Anaesth. 2002;88:467–469. [CrossRef] [Google Scholar]
  2. Murray DJ, William BJ, Pennell B, et al. Heparin detection by the activated coagulation time: A comparison of the sensitivity of coagulation tests and heparin assays. J Cardiothorac Vasc Anesth. 1997;11:24–28. [CrossRef] [Google Scholar]
  3. Bull BS, Huse WM, Brauer FS, Korpman RA. Heparin therapy during extracorporeal circulation II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–689. [CrossRef] [Google Scholar]
  4. Despotis GJ, Santoro SA, Spitznagel E, et al. Prospective evaluation and clinical utility of on-site monitoring of coagulation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1994;107:271–279. [CrossRef] [Google Scholar]
  5. Slight RD, Buell R, Nzewi OC, McClelland DBL, Mankad PS. A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2008;22:47–52. [CrossRef] [Google Scholar]
  6. Culliford AT, Gitel SN, Starr N, et al. Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. Ann Surg. 1981;193:105–111. [CrossRef] [PubMed] [Google Scholar]
  7. Despotis GJ, Summerfield AL, Joist JH, et al. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations. J Thorac Cardiovasc Surg. 1994;108:1076–1082. [CrossRef] [Google Scholar]
  8. Despotis GJ, Grishaber JE, Goodnough LT. The effect of an intraoperative treatment algorithm on physicians’ transfusion practice in cardiac surgery. Transfusion. 1994;34:290–296. [CrossRef] [PubMed] [Google Scholar]
  9. Ak K, Isbir CS, Tetik S, et al. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: A prospective randomized study. J Card Surg. 2009;24:404–410. [CrossRef] [Google Scholar]
  10. Jobes DR, Aitken GL, Shaffer GW. Increased accuracy and precision of heparin and protamine dosing reduces blood loss and transfusion in patients undergoing primary cardiac operations. J Thorac Cardiovasc Surg. 1995;110:36–45. [CrossRef] [Google Scholar]
  11. FitzGerald DJ, Patel A, Body SC, Garvin S. The relationship between heparin level and activated clotting time in the adult cardiac surgery population. Perfusion. 2009;24:93–96. [CrossRef] [PubMed] [Google Scholar]
  12. Ferraris VA, Ferraris SP, Saha SP, et al. Periopertive blood transfusion and blood conservation in cardiac surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83: S27–S86. [CrossRef] [Google Scholar]
  13. Kost GJ. Guidelines for point-of-care testing. Improving patient outcomes. Am J Clin Pathol. 1995;104:S111–S127. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.